A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers
Open accessThe DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Abstract
Antibiotics (ABX) compromise the efficacy of programmed cell death protein 1 (PD-1) blockade in cancer patients, but the mechanisms underlying their immunosuppressive effects remain unknown. By inducing the down-regulation of mucosal addressin cell adhesion molecule 1 (MAdCAM-1) in the ileum, post-ABX gut recolonization by Enterocloster species drove the emigration of enterotropic α4β7 + CD4 + regulatory T 17 cells into the tumor. These deleterious ABX effects were mimicked by oral gavage of Enterocloster species, by genetic deficiency, or by antibody-mediated neutralization of MAdCAM-1 and its receptor, α4β7 integrin. By contrast, fecal microbiota transplantation or interleukin-17A neutralization prevented ABX-induced immunosuppression. In independent lung, kidney, and bladder cancer patient cohorts, low serum levels of soluble MAdCAM-1 had a negative prognostic impact. Thus, the MAdCAM-1–α4β7 axis constitutes an actionable gut immune checkpoint in cancer immunosurveillance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Intestinal dysbiosis, broadly defined as an imbalance in the composition or function of the gut microbiota, is a significant contributor to resistance against immune checkpoint inhibitor (ICI) therapies.1–16,”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [4]
In the citing paper
“Antibiotics predictably inflict the most acute damage, reducing diversity, depleting beneficial commensals, and permitting blooms of pathobionts like Enterocloster and Streptococcus.4,27,98”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [4]
In the citing paper
“For instance, our lab has shown that antibiotic-induced dysbiosis spurs the downregulation of mucosal vascular addressin cell adhesion molecule 1 (MAdCAM-1; discussed below) via altered BA metabolism (Fig. 3h).4”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [4]
In the citing paper
“Our lab recently reported that low baseline sMAdCAM-1 levels are strongly associated with gut dysbiosis in cancer patients.4,24”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [4]
In the citing paper
“This, in turn, allows immunosuppressive gut-resident α4β7+FoxP3+ regulatory Th17 (Tr17) cells to exit the gut and migrate to peripheral tumors, where they can blunt local antitumor immunity.4”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [4]
26 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192
Self-citationQuPath: Open source software for digital pathology image analysis
Bankhead, P., Loughrey, M. B., Fernández, J. A., Dombrowski, Y., McArt, D. G., Dunne, P. D., McQuaid, S., Gray, R. T., Murray, L. J., Coleman, H. G., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17204-5 · Cited by 8,908
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
Brahmer, J., Reckamp, K. L., Baas, P., Crinò, L., Eberhardt, W. E. E., Poddubskaya, E., Antonia, S., Pluzanski, A., Vokes, E. E., Holgado, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504627 · Cited by 8,447 · cited 1×
“I mmune checkpoint inhibitors (ICIs) targeting the immunosuppressive interaction between programmed cell death protein 1 (PD-1) and programmed death-ligand 1 (PD-L1) are used in the clinical management of many cancer types (1, 2).”
MethodGut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671 · cited 3×
“Moreover, FMT from some human donors fails to improve ICI responses (7, 35).”
BackgroundMethodSelf-citationIpilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Robert, C., Thomas, L., Bondarenko, I., O'Day, S., Weber, J., Garbe, C., Lebbe, C., Baurain, J.-F., Testori, A., Grob, J.-J., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1104621 · Cited by 4,496 · cited 2×
“I mmune checkpoint inhibitors (ICIs) targeting the immunosuppressive interaction between programmed cell death protein 1 (PD-1) and programmed death-ligand 1 (PD-L1) are used in the clinical management of many cancer types (1, 2).”
BackgroundMethodVedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Feagan, B. G., Rutgeerts, P., Sands, B. E., Hanauer, S., Colombel, J.-F., Sandborn, W. J., Van Assche, G., Axler, J., Kim, H.-J., Danese, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215734 · Cited by 2,888
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Spranger, S., Bao, R., & Gajewski, T. F. (2015) · Nature · doi:10.1038/nature14404 · Cited by 2,830 · cited 1×
“, A novel endothelial L-selectin ligand activity in lymph node medulla that is regulated by alpha(1,3)fucosyltransferase-IV.”
BackgroundMultivariable association discovery in population-scale meta-omics studies
Mallick, H., Rahnavard, A., McIver, L. J., Ma, S., Zhang, Y., Nguyen, L. H., Tickle, T. L., Weingart, G., Ren, B., Schwager, E. H., et al. (2021) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1009442 · Cited by 2,596
Cited by
Items 201–244 of 244
Koleva, P. T., He, J., Dunsmore, G., Bozorgmehr, N., Lu, J., Huynh, M., Tollenaar, S. L., Huang, V., Walter, J., Way, S. S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26755759
Koleva, P. T., He, J., Dunsmore, G., Bozorgmehr, N., Lu, J., Huynh, M., Tollenaar, S. L., Huang, V., Walter, J., Way, S. S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26755756
Kong, D., Wu, Y., Liu, Q., Huang, C., Wang, T., Huang, Z., Gao, Y., Li, Y., & Guo, H. (2024) · Figshare · doi:10.6084/m9.figshare.26705742
Koleva, P. T., He, J., Dunsmore, G., Bozorgmehr, N., Lu, J., Huynh, M., Tollenaar, S. L., Huang, V., Walter, J., Way, S. S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26755753
Luo, W., Mei, S.-Q., Huang, Z.-J., Chen, Z.-H., Zhang, Y.-C., Yang, M.-Y., Liu, J.-Q., Xu, J.-Y., Yang, X.-R., Zhong, R., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25530414
Luo, W., Mei, S.-Q., Huang, Z.-J., Chen, Z.-H., Zhang, Y.-C., Yang, M.-Y., Liu, J.-Q., Xu, J.-Y., Yang, X.-R., Zhong, R., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25530316
Hao, J., Hongjin, L. I. U., Guo, T., Zhang, Q., Wang, X., An, L., & Xu, S. (2025) · BMC Microbiology · doi:10.1186/s12866-025-04530-2
Pu, Z., Peng, Y., Chen, X., Ma, Y., Liu, Y., & Li, X. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157755 · Cited by 1
Beyond Sterility: the Urinary Microbiome in Bladder Cancer Carcinogenesis and Treatment
Aron, S. L., Meagher, M. F., Azari, S., Baker, B. H., Nasseri, R., Bagrodia, A., Stewart, T. F., Liss, M. A., & Salmasi, A. (2026) · Current Urology Reports · doi:10.1007/s11934-025-01315-y
Wu, R., Batu, B., Badarch, J., Tsagaankhuu, S., Jiang, X., Chen, J., & Boldbaatar, D. (2026) · medRxiv · doi:10.64898/2026.01.30.26345189
Self-citationZhang, W., Li, W., Zhang, Z., Sun, P., & Wu, G. (2026) · Research Square · doi:10.21203/rs.3.rs-8616596/v1
Soluble mucosal addressin cell adhesion molecule 1 is a biomarker for pediatric ulcerative colitis
Muschaweck, M., Gutbier, C., Sellge, G., Pappa, A., Wenzl, T. G., Hamesch, K., Wagner, N., & Schippers, A. (2026) · Molecular and Cellular Pediatrics · doi:10.1186/s40348-026-00221-8
Self-citationRe: Soluble MAdCAM-1 as a Biomarker in Metastatic Renal Cell Carcinoma
Li, Y., Liu, Y., Lu, B., Yao, Y., Lyu, D., Zhang, H. X., Cui, X., & Pan, X. (2026) · European Urology · doi:10.1016/j.eururo.2026.02.005
Microbiome and EGFR -mutant non-small cell lung cancer: a complex interplay
Eccher, S., Sposito, M., Scaglione, I. M., Pasqualin, L., Rota, M., Bonato, A., Longo, L., Avancini, A., Trestini, I., Tregnago, D., et al. (2026) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2026.2645844
Gut microbiota-related biomarkers in immuno-oncology
Silva, C. A. C. (2023) · theses.fr (ABES) · doi:10.70675/9022496ez0bbbz4f94z9760z4ae0a6ee5e7a
Kalinina, N. Y. (2026) · Ukrainian Journal of Urology · doi:10.71217/uju.1(9).2026.36-43
A “healthy gut state” as the key determinant of immune checkpoint inhibitor efficacy
Sokol, H., Elkrief, A., & Routy, B. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.04.034
Self-citationQiao, S., Yang, L., Hao, H., Ding, Q., Ding, F., Chen, Z., Zhang, J., He, Y., Li, M., Xu, J., et al. (2026) · Advanced Science · doi:10.1002/advs.202519942
Discovering Predictive Biomarkers in Renal Cell Carcinoma
Porta, C., Ganini, C., Rizzo, M., & Cosmai, L. (2026) · European Urology Oncology · doi:10.1016/j.euo.2026.03.012
Mitochondrial metabolism as a pharmacological target for cancer therapeutics
Yu, Y., Ding, W., Liu, S., Glorieux, C., Liu, P., & Huang, P. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100137
Wu, R., Batu, B., Badarch, J., Tsagaankhuu, S., Jiang, X., Chen, J., & Boldbaatar, D. (2026) · 3 Biotech · doi:10.1007/s13205-026-04819-7
Self-citationOvercoming resistance to anti-PD-1/PD-L1 therapy in cancer
Li, L., Zhao, Y., Shi, X., Guo, X., Zhang, X., Li, G., Meng, Q., Zhang, M., & Yin, M. (2026) · Cancer Drug Resistance · doi:10.20517/cdr.2026.12
A single-strain dropout screen reveals mechanistic links between microbial ecology and metabolismPreprint
Zeng, X., Meng, X., Weakley, A. M., Higginbottom, S. K., Lopez, E. M., Cabrera, A. V., Gray, I. J., DeFelice, B. C., Terasaki, M., Zhao, A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.23.727446
The impact of gut microbiota and metabolite-driven immune cell spatiotemporal dynamics on tumors
Ding, J., Lin, M., Zang, D., & Chen, J. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2681842 · Cited by 1
Self-citationLymphocyte homing disorder: a concealed driver of intestinal immune collapse in sepsis
Geng, H., Xiong, D., Lü, X., Wang, J., Chen, H. Y., & Jia, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1827322
Modulating commensal microbiota: shifting from broad interventions to precision control
Yu, W., & Zheng, D. (2026) · Scientia Sinica Vitae · doi:10.1360/ssv-2025-0417
Su, X., Xiang, Y., Zhao, H., Li, O., Zhang, L., & Guo, B. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1839030 · Cited by 1
Rani, R., Adhikari, A., & Kumar, S. (2026) · Advanced Gut & Microbiome Research · doi:10.1155/agm3/9526059
Luo, W., Huang, Z., Mei, S., Zhang, Q., Chen, Z., Chen, P.-P., Huang, G.-H., Wang, F., Deng, Y., Tu, H.-Y., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08580-6 · Cited by 1
Gouveia, L., Serpa, J., & Mendes, C. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-3-032-12166-0_3
Dysbiosis-associated bile acids slam the brakes on immune checkpoint therapy
Wong, C. C., & Yu, J. Q. (2026) · Cancer Cell · doi:10.1016/j.ccell.2026.06.013
Zhuo, P., Luo, Z., Luo, X., Wang, H., Dong, C., & Li, Q. (2026) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-026-00935-9
Chen, Y., Nian, F., Wu, S., Yuan, T., Ma, Y., Cao, J., Zhang, Y., Liu, W., Tang, W., Zhang, D., et al. (2026) · Nature Cancer · doi:10.1038/s43018-026-01222-2 · Cited by 3
Ma, J., Zeng, Y., Wang, X., Liu, Y., Xiao, D., Zhou, B., Cai, N., & Qiang, R. (2026) · ACS Applied Nano Materials · doi:10.1021/acsanm.6c02789
Pinon, L., Debache, A., Thuaud, A., Tiraboschi, L., Vella, G., Riou-Ramon, J., Cordier, C., Helal, C., Hersen, P., Rescigno, M., et al. (2026) · Communications Biology · doi:10.1038/s42003-026-10675-1
Хамидов, Ф., Jalolov, O., Nematov, U., Ilmira, U., Mavlyuda, Q., Sayfullayevna, S. M., Alkhawaja, A. S., Gulkhayyo, J., & Siahmansouri, H. (2026) · Seminars in Oncology · doi:10.1016/j.seminoncol.2026.152564
Gut microbiome in immuno-oncology: potential for clinical exploitation
Margarita, E., Saito, K., Bisegna, P., Ferrari, M., Valeriani, E., Guerrieri, M., Funaro, B., Feliciani, D., Gasbarrini, A., Porcari, S., et al. (2026) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2026.102143
The Gut–Prostate Axis: Mechanistic Insights and Nanotechnology Driven Therapeutic Strategies
Mansour, R. M., Salah, A. N., Mageed, S. S. A., El-Sayyad, G. S., Rizk, N. I., Gaballah, M. S. A., zakaria, G., Abdelaziz, M. M., Fahmy, H. A., Shaker, A. A. S., et al. (2026) · Comprehensive physiology · doi:10.1002/cph4.70274
Yang, J., Cai, X., He, F., 张君红, Zhang, Z., Yi, Z., Xie, C., & Xu, B. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02903-1
Pleiotropic roles of microbial bile acid metabolism in intestinal health and diseases
Qi, M., Liu, X., & Gonzalez, F. J. (2026) · Cell Host & Microbe · doi:10.1016/j.chom.2026.09.010
Biomarkers of subclinical cholestasis predict cancer immunotherapy outcomes
Varende, A.-L. M. D. L., Fidelle, M., Kroemer, G., & Zitvogel, L. (2026) · OncoImmunology · doi:10.1080/2162402x.2026.2748140
Self-citationZhao, N., Zhang, H., Pang, Y., Zhu, L., Liu, Q., Zhang, Z., Shen, L., He, Y., & Lin, S. (2026) · Experimental Hematology and Oncology · doi:10.1186/s40164-026-00840-x
Zhang, T., Hu, X., Yang, S., Sun, H., Zhang, R., Pang, Z., Chen, M., Ge, M., & Luo, Y. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124710
Antibiotics and outcomes of cancer immunotherapy: An updated meta-analysis and clinical applications
Porcari, S., Bolte, L. A., Björk, J. R., Elkrief, A., Derosa, L., Ferrari, M., Pezzullo, A. M., Severino, A., Fusco, W. G., Messaoudene, M., et al. (2026) · Cancer Cell · doi:10.1016/j.ccell.2026.09.012
Self-citation
Metadata
- Authors
- Fidelle, M., Rauber, C., Alves Costa Silva, C., Tian, A.-L., Lahmar, I., de La Varende, A.-L. M., Zhao, L., Thelemaque, C., Lebhar, I., Messaoudene, M., Pizzato, E., Birebent, R., Mbogning Fonkou, M. D., Zoppi, S., Reni, A., Dalban, C., Leduc, M., Ferrere, G., Durand, S., Ly, P., Silvin, A., Mulder, K., Dutertre, C.-A., Ginhoux, F., Yonekura, S., Roberti, M. P., Tidjani-Alou, M., Terrisse, S., Chen, J., Kepp, O., Schippers, A., Wagner, N., Suárez-Gosálvez, J., Kobold, S., Fahrner, J.-E., Richard, C., Bosq, J., Lordello, L., Vitali, G., Galleron, N., Quinquis, B., Le Chatelier, E., Blanchard, L., Girard, J.-P., Jarry, A., Gervois, N., Godefroy, E., Labarrière, N., Koschny, R., Daillère, R., Besse, B., Truntzer, C., Ghiringhelli, F., Coatnoan, N., Mhanna, V., Klatzmann, D., Drubay, D., Albiges, L., Thomas, A. M., Segata, N., Danlos, F.-X., Marabelle, A., Routy, B., Derosa, L., Kroemer, G., & Zitvogel, L.
- Affiliations
- Inserm (FR)
- Gustave Roussy Cancer Campus, Villejuif Cedex, France.
- Centre Hospitalier de l’Université de Montréal (CA)
- University of Parma (IT)
- University of Verona (IT)
- Centre Léon Bérard (FR)
- Universitätsklinikum Aachen (DE)
- Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU Munich, Germany.
- Center for Integrated Protein Science Munich (DE)
- JBO Consultant, Paris, France.
- Université Paris-Saclay (FR)
- MetaGenoPolis, INRAe, Université Paris-Saclay, Jouy en Josas, France.
- Centre National de la Recherche Scientifique (FR)
- University Hospital Heidelberg (DE)
- Institut Gustave Roussy (FR)
- University of Trento (IT)
- Corresponding author
- Fidelle, Marine
- Rauber, Conrad
- Derosa, Lisa
- Kroemer, Guido
- Zitvogel, Laurence
- ORCID
- Fidelle, Marine
- Rauber, Conrad
- Alves Costa Silva, Carolina
- Tian, Ai-Ling
- Zhao, Liwei
- Messaoudene, Meriem
- Birebent, Roxanne
- Mbogning Fonkou, Maxime Descartes
- Zoppi, Silvia
- Reni, Anna
- Dalban, Cécile
- Leduc, Marion
- Ferrere, Gladys
- Durand, Sylvère
- Ly, Pierre
- Silvin, Aymeric
- Mulder, Kevin
- Dutertre, Charles-Antoine
- Ginhoux, Florent
- Yonekura, Satoru
- Roberti, Maria Paula
- Tidjani-Alou, Maryam
- Terrisse, Safae
- Chen, Jianzhou
- Kepp, Oliver
- Schippers, Angela
- Wagner, Norbert
- Suárez-Gosálvez, Javier
- Kobold, Sebastian
- Fahrner, Jean-Eudes
- Richard, Corentin
- Bosq, Jacques
- Lordello, Leonardo
- Galleron, Nathalie
- Quinquis, Benoît
- Le Chatelier, Emmanuelle
- Blanchard, Lucas
- Girard, Jean-Philippe
- Jarry, Anne
- Gervois, Nadine
- Godefroy, Emmanuelle
- Labarrière, Nathalie
- Koschny, Ronald
- Daillère, Romain
- Besse, Benjamin
- Truntzer, Caroline
- Ghiringhelli, François
- Coatnoan, Nicolas
- Mhanna, Vanessa
- Klatzmann, David
- Drubay, Damien
- Albiges, Laurence
- Thomas, Andrew Maltez
- Segata, Nicola
- Danlos, François-Xavier
- Marabelle, Aurélien
- Routy, Bertrand
- Derosa, Lisa
- Kroemer, Guido
- Zitvogel, Laurence
- Venue
- Science
- Published
- 2023-06-09
- Volume
- 380
- Issue
- 6649
- Pages
- eabo2296-eabo2296
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W4379780265
- Cited by
- 243
- References
- 83
- Citations by year
- 2026: 74 · 2025: 86 · 2024: 58 · 2023: 25
- FWCI
- 29.63
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Science (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RWTH Publications (RWTH Aachen) (publishedVersion)
- HAL (submittedVersion)
- HAL (submittedVersion, other-oa)
- Institutional Research Information System (Università degli Studi di Trento) (submittedVersion, cc-by)
- Funders
- Agence Nationale de la Recherche (ANR-16-RHUS-0001, ANR-21-ESRE-0028, ANR-18-IBHU-0002, ANR-19-CE15-0029, ANR-21-RHUS-0017, ANR-18-IDEX-0001)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- antibiotics, gut microbiota, MAdCAM-1, alpha4beta7 integrin, regulatory T cells, anti-PD-1 therapy, tumor immunosuppression, Enterocloster, fecal microbiota transplantation, IL-17A, prognostic factors, lung cancer, kidney cancer, bladder cancer
- MeSH terms
- Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Immune Checkpoint Inhibitors, Animals, Anti-Bacterial Agents, Bacteria, Cell Movement, Humans, Immune Tolerance, Immunologic Surveillance, Mucoproteins, Neoplasms, Cell Adhesion Molecules, Integrins, Drug Resistance, Neoplasm, Interleukin-17, Gastrointestinal Tract, Mice, Th17 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.